tradingkey.logo

LeMaitre Vascular Inc

LMAT
View Detailed Chart

92.370USD

+0.080+0.09%
Close 09/15, 16:00ETQuotes delayed by 15 min
2.09BMarket Cap
44.38P/E TTM

LeMaitre Vascular Inc

92.370

+0.080+0.09%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.09%

5 Days

-4.84%

1 Month

-3.69%

6 Months

+12.77%

Year to Date

+0.25%

1 Year

+2.99%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated2025-09-15

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a very weak market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
8 / 207
Overall Ranking
88 / 4724
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 11 analysts
Buy
Current Rating
104.778
Target Price
+13.53%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Its portfolio of product lines is primarily used to treat vascular disease, of which most are used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy catheters, occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. The Company’s principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. The Company sells its products and services primarily through a direct sales force.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 36.01% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 113.40.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 32.65%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 32.65%.
Undervalued
The company’s latest PE is 44.20, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 23.37M shares, decreasing 3.01% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 1.60M shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.42.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Its portfolio of product lines is primarily used to treat vascular disease, of which most are used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy catheters, occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. The Company’s principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. The Company sells its products and services primarily through a direct sales force.
Ticker SymbolLMAT
CompanyLeMaitre Vascular Inc
CEOMr. George W. Lemaitre
Websitehttps://www.lemaitre.com/
KeyAI